Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
2,534,263
-
Total 13F shares
-
37,209,083
-
Share change
-
-1,606,320
-
Total reported value
-
$74,791,408
-
Put/Call ratio
-
2%
-
Price per share
-
$2.01
-
Number of holders
-
78
-
Value change
-
-$3,461,406
-
Number of buys
-
39
-
Number of sells
-
28
Institutional Holders of Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) as of Q4 2022
As of 31 Dec 2022 Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) had 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 37,209,083 shares of stock of the company.
Largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), UBS Group AG, ARCH Venture Management, LLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, FMR LLC, COATUE MANAGEMENT LLC, VANGUARD GROUP INC, Casdin Capital, LLC, and STATE STREET CORP.
This table shows 78 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.